Top Performing Leveraged/Inverse ETFs: 04/19/2026

Top Performing Leveraged/Inverse ETFs Last WeekThese were last week’s top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly. Always do your homework.1. IONX – Defiance Daily Target 2X Long IONQ ETF
The Defiance Daily Target 2X Long IONQ ETF, which seeks daily leveraged investment results of two times the daily percentage change in the share price of IonQ Inc., topped the levered ETFs’ list last week with ~138% returns. IonQ shares surged last week following a DARPA contract to develop high-speed quantum interconnects. This growth was further fueled by breakthroughs in trapped-ion networking and positive market sentiment linked to Nvidia’s new quantum-AI models.
2. HIMZ – Defiance Daily Target 2X Long HIMS ETF
HIMZ seeks to deliver 2x leveraged exposure to the daily share price movement of Hims & Hers Health Inc. ranked second on the levered ETFs list last week, fueled by the FDA announcing July advisory sessions to review easing restrictions on several peptides, which could boost the company’s compounded drug offerings.
3. OKLL – Defiance Daily Target 2x Long OKLO ETF
OKLL seeks to deliver 2x leveraged exposure to the daily share price movement of Oklo Inc. Class A (NYSE: OKLO) was another prospect on the list with over 72% weekly gains. Oklo’s stock increased last week, driven by new White House directives favoring space-based nuclear energy and strong momentum for SMRs. Investor optimism was further bolstered by strategic board updates and progress on the Aurora reactor for data center applications.
4. ROBN – T-Rex 2X Long HOOD Daily Target ETF
ROBN, which aims to provide 2x leveraged exposure to the daily price movement of Robinhood Markets Inc. stock, also made it to the list. Robinhood shares jumped last week, following the SEC’s removal of the $25,000 minimum balance rule for pattern day traders. This regulatory shift eliminates a major barrier for retail investors, signaling a significant expected boost to the platform’s trading volumes and revenue.
5. HOOX – Defiance Daily Target 2X Long HOOD ETF
HOOX, which seeks to provide 2x leveraged exposure to the daily share price movement of Robinhood Markets, Inc. (Nasdaq: HOOD), was another leveraged ETF on this week’s list with ~67% gains.
6. MSTU – T-Rex 2X Long MSTR Daily Target ETF
MSTU, which aims to provide 2x leveraged exposure to the daily price movement of MicroStrategy Inc. stock (NASDAQ: MSTR), was present on the list. MicroStrategy shares increased last week, as Bitcoin surpassed $77,000 and the company acquired an additional BTC. As a primary institutional proxy for the asset, MSTR’s surge reflects its massive BTC treasury and renewed market optimism.
7. MSTX – Defiance Daily Target 2x Long MSTR ETF
MSTX, which seeks to provide 2x leveraged exposure to the daily share price movement of MicroStrategy Inc. (NYSE: MSTR), also made it to the list with 64% returns in the last week.
8. MST – Defiance Leveraged Long Income MSTR ETF
MST was another MicroStrategy-focused fund on the top-performing levered/ inverse ETFs last week, with nearly ~54% weekly gains.
9. CONL – GraniteShares 2x Long COIN Daily ETF
CONL ETF, which provides 2x leveraged exposure to the daily price movement for shares of Coinbase stock, was present on the list with over 49% weekly returns. Coinbase (NASDAQ: COIN) stock rose, driven by a broader cryptocurrency market rally, rising Bitcoin prices, and positive sentiment within the tech sector.
10 .KBDU – KraneShares 2x Long BIDU Daily ETF
KBDU, which provides 2x leveraged exposure to the daily price movement of Baidu, Inc. Sponsored ADR Class A (NASDAQ: BIDU), was another contender on the levered ETFs list. BAIDU shares gained last week, driven by optimism regarding its AI business, autonomous driving, and positive analyst sentiment.
For more news, information, and analysis, visit the Leveraged & Inverse Content Hub.
Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.
ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.
For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.
FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.
News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.
Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.
Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.